The Korean Society of Hematology

Academic/Hospital

Also known as: Korean Society of Hematology | The Korean Society of Hematology, AML/MDS Working Party | The Korean Society of Hematology CML working party

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Sep 1, 2012

Last known activity

Jan 30, 2025

Timeline

No events for the selected filters.

Drugs by trial phase (5 distinct, 4 trials)

Phase 2 (5 own, 0 via acquisition)

decitabine
venetoclax
selinexor
nilotinib
asciminib

Indications

Studied for

Blast Crisis
Leukemia
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Leukemia, Myeloid
Leukemia, Myeloid, Acute

Recent trials (5)

NCT06712121CollaboratorPhase 2Jan 30, 2025
NCT06368414Lead sponsorPhase 2Sep 1, 2024
NCT06368414OfficialPhase 2Sep 1, 2024
NCT06552559CollaboratorPhase 1/Phase 2May 1, 2024
NCT01690065CollaboratorPhase 2Sep 1, 2012

Details

Last known activity: Jan 30, 2025